Liu; Zhi-Ren

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liu; Zhi-Ren.The latest application filed is for "system and methods to promote cellular regeneration following ischemia".

Company Profile

3.13.17

Liu; Zhi-Ren - Marietta GA
LIU; Zhi-Ren - Atlanta GA
Liu; Zhi-Ren - Athens GA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method to prevent cancer metastasis and inhibit inflammation by inhibition of p68 interaction with calmodulin Grant 11,214,624 - Liu , et al. January 4, 2	2022-01-04
System And Methods To Promote Cellular Regeneration Following Ischemia App 20200368329 - LIU; Zhi-Ren	2020-11-26
Targeted Contrast Agents And Methods For Targeting Contrast Agents App 20200108158 - Yang; Jenny J. ; et al.	2020-04-09
Targeted contrast agents and methods for targeting contrast agents Grant 10,525,150 - Yang , et al. J	2020-01-07
Protein to promote blood vessel growth and uses thereof Grant 10,213,493 - Liu , et al. Feb	2019-02-26
Molecules Disrupting Pyruvate Kinase M2 And Integrin Interaction And Uses Thereof App 20180072812 - LIU; Zhi-Ren ; et al.	2018-03-15
Integrin-targeting Protein And Methods Of Use Thereof App 20180044403 - Liu; Zhi-Ren ; et al.	2018-02-15
Therapeutic Proteins For Treating Cancers And Methods For Using Such Proteins App 20170226170 - Liu; Zhi-Ren	2017-08-10
Targeted Contrast Agents And Methods For Targeting Contrast Agents App 20160250356 - Yang; Jenny J. ; et al.	2016-09-01
Targeted contrast agents and methods for targeting contrast agents Grant 9,339,559 - Yang , et al. May 17, 2	2016-05-17
Anti-angiogenic Agent And Methods Of Using Such Agent App 20160090408 - Liu; Zhi-Ren ; et al.	2016-03-31
Pyruvate Kinase M2 Neutralizing Antibodies For Inhibiting Angiogenesis App 20160002347 - Liu; Zhi-Ren ; et al.	2016-01-07
Protein To Promote Blood Vessel Growth And Uses Thereof App 20150374799 - LIU; Zhi-Ren ; et al.	2015-12-31
Anti-angiogenic agent and methods of using such agent Grant 9,175,063 - Liu , et al. November 3, 2	2015-11-03
Method To Prevent Cancer Metastasis And Inhibit Inflammation By Inhibition Of P68 Interaction With Calmodulin App 20150037342 - Liu; Zhi-Ren ; et al.	2015-02-05
Protein agent for diabetes treatment and .beta. cell imaging Grant 8,697,648 - Liu , et al. April 15, 2	2014-04-15
Anti-angiogenic Agent And Methods Of Using Such Agent App 20130281357 - Liu; Zhi-Ren ; et al.	2013-10-24
Contrast agents and methods for preparing contrast agents Grant 8,367,040 - Yang , et al. February 5, 2	2013-02-05
Contrast Agents and Methods for Preparing Contrast Agents App 20120269735 - Yang; Jenny J. ; et al.	2012-10-25
Protein Agent For Diabetes Treatment And Beta Cell Imaging App 20120244080 - Liu; Zhi-Ren ; et al.	2012-09-27
Contrast agents and methods for preparing contrast agents Grant 8,173,105 - Yang , et al. May 8, 2	2012-05-08
Phosphorylated p68 RNA helicase as a marker for cancer and cancer metastasis Grant 7,741,066 - Liu June 22, 2	2010-06-22
Targeted Contrast Agents And Methods For Targeting Contrast Agents App 20090104123 - Yang; Jenny J. ; et al.	2009-04-23
Contrast Agents And Methods For Preparing Contrast Agents App 20090087382 - Yang; Jenny J. ; et al.	2009-04-02
Phosphorylated p68 RNA helicase as a marker for cancer and cancer metastasis App 20080014597 - Liu; Zhi-Ren	2008-01-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.